0001976408-24-000032.txt : 20240201 0001976408-24-000032.hdr.sgml : 20240201 20240201101341 ACCESSION NUMBER: 0001976408-24-000032 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240201 DATE AS OF CHANGE: 20240201 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 24585348 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Schoenberg Mark CENTRAL INDEX KEY: 0001763581 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 9 HA TA ASIYA STREET CITY: RA ANANA STATE: L3 ZIP: 4365007 144 1 primary_doc.xml 144 0001763581 XXXXXXXX LIVE 0001668243 UroGen Pharma Ltd. 001-38079 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601 Schoenberg Mark Officer Ordinary Oppenheimer & Co. Inc.

85 Broad St. New York NY 10004

3789 59979.87 30866320 01/31/2024 NASDAQ Ordinary 01/31/2021 Restricted Stock Units Issuer N 6000 01/31/2021 N/A Ordinary 01/31/2022 Restricted Stock Units Issuer N 4000 01/31/2022 N/A Ordinary 01/31/2023 Restricted Stock Units Issuer N 10000 01/31/2023 N/A Y 01/31/2024 Mark Schoenberg